Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 62/296,296, filed Feb 17, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,059,710 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence | ||
| US 10,336,758 | New stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence | ||
| US 10,570,134 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence | ||
| US 11,306,094 | Stable Formulations of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid In force · High confidence | Merck & Cie | In force | High confidence | ||
| US 12,103,930 | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid In force · High confidence | Merck & Cie | In force | High confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.